Back to News
Market Impact: 0.1
BetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
Source: feeds.newsfilecorp.com
Healthcare & BiotechRegulation & Legislation
BetterLife Pharma announced that its final prospectus is accessible through SEDAR+. The provided article text contains no financing terms, securities issuance details, clinical updates, or other material financial information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- USTR Greer tells EU that loan to Airbus threatens trade truce on aircraft financing
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation
- Iran’s anti-negotiation hardliners turn against President Pezeshkian
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Anthropic publicly files for listing on the US stock market
- ‘Imposed significant financial harm’: 20 states join the FTC in suing Dollar General for ‘deceptive pricing practices’ despite ‘corporate knowledge’